BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1021 related articles for article (PubMed ID: 27884168)

  • 1. Ataxia telangiectasia: a review.
    Rothblum-Oviatt C; Wright J; Lefton-Greif MA; McGrath-Morrow SA; Crawford TO; Lederman HM
    Orphanet J Rare Dis; 2016 Nov; 11(1):159. PubMed ID: 27884168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ataxia-telangiectasia: A review of clinical features and molecular pathology.
    Amirifar P; Ranjouri MR; Yazdani R; Abolhassani H; Aghamohammadi A
    Pediatr Allergy Immunol; 2019 May; 30(3):277-288. PubMed ID: 30685876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ataxia-telangiectasia, an evolving phenotype.
    Chun HH; Gatti RA
    DNA Repair (Amst); 2004; 3(8-9):1187-96. PubMed ID: 15279807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute lymphoblastic leukemia in early childhood as the presenting sign of ataxia-telangiectasia variant.
    Bielorai B; Fisher T; Waldman D; Lerenthal Y; Nissenkorn A; Tohami T; Marek D; Amariglio N; Toren A
    Pediatr Hematol Oncol; 2013 Sep; 30(6):574-82. PubMed ID: 23509889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cerebellar degeneration in ataxia-telangiectasia: A case for genome instability.
    Shiloh Y
    DNA Repair (Amst); 2020 Nov; 95():102950. PubMed ID: 32871349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ataxia telangiectasia syndrome: moonlighting ATM.
    Zaki-Dizaji M; Akrami SM; Abolhassani H; Rezaei N; Aghamohammadi A
    Expert Rev Clin Immunol; 2017 Dec; 13(12):1155-1172. PubMed ID: 29034753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ataxia-telangiectasia presenting with a novel immunodeficiency.
    Perreault S; Bernard G; Lortie A; Le Deist F; Decaluwe H
    Pediatr Neurol; 2012 May; 46(5):322-4. PubMed ID: 22520355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel, ataxic mouse model of ataxia telangiectasia caused by a clinically relevant nonsense mutation.
    Perez H; Abdallah MF; Chavira JI; Norris AS; Egeland MT; Vo KL; Buechsenschuetz CL; Sanghez V; Kim JL; Pind M; Nakamura K; Hicks GG; Gatti RA; Madrenas J; Iacovino M; McKinnon PJ; Mathews PJ
    Elife; 2021 Nov; 10():. PubMed ID: 34723800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactive Atm abrogates DSB repair in mouse cerebellum more than does Atm loss, without causing a neurological phenotype.
    Tal E; Alfo M; Zha S; Barzilai A; De Zeeuw CI; Ziv Y; Shiloh Y
    DNA Repair (Amst); 2018 Dec; 72():10-17. PubMed ID: 30348496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two novel variants in the ATM gene causing ataxia-telangiectasia, including a duplication of 90 kb: Utility of targeted next-generation sequencing in detection of copy number variation.
    Martin-Rodriguez S; Calvo-Ferrer A; Ortega-Unanue N; Samaniego-Jimenez L; Sanz-Izquierdo MP; Bernardo-Gonzalez I
    Ann Hum Genet; 2019 Jul; 83(4):266-273. PubMed ID: 30888062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel ATM mutations with ataxia-telangiectasia.
    Liu XL; Wang T; Huang XJ; Zhou HY; Luan XH; Shen JY; Chen SD; Cao L
    Neurosci Lett; 2016 Jan; 611():112-5. PubMed ID: 26628246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ataxia-telangiectasia: mild neurological presentation despite null ATM mutation and severe cellular phenotype.
    Alterman N; Fattal-Valevski A; Moyal L; Crawford TO; Lederman HM; Ziv Y; Shiloh Y
    Am J Med Genet A; 2007 Aug; 143A(16):1827-34. PubMed ID: 17632790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype-phenotype relationships in ataxia-telangiectasia and variants.
    Gilad S; Chessa L; Khosravi R; Russell P; Galanty Y; Piane M; Gatti RA; Jorgensen TJ; Shiloh Y; Bar-Shira A
    Am J Hum Genet; 1998 Mar; 62(3):551-61. PubMed ID: 9497252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ataxia telangiectasia.
    Nissenkorn A; Ben-Zeev B
    Handb Clin Neurol; 2015; 132():199-214. PubMed ID: 26564081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ataxia telangiectasia. A prototype of neurological involvement in primary immune deficiencies].
    Liptai Z
    Orv Hetil; 2018 Dec; 159(49):2057-2064. PubMed ID: 30525879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studying the cerebellar DNA damage response in the tissue culture dish.
    Tzur-Gilat A; Ziv Y; Mittelman L; Barzilai A; Shiloh Y
    Mech Ageing Dev; 2013 Oct; 134(10):496-505. PubMed ID: 23583690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart.
    Shiloh Y
    Annu Rev Genet; 1997; 31():635-62. PubMed ID: 9442910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ataxia-Telangiectasia Presenting as Cerebral Palsy and Recurrent Wheezing: A Case Report.
    Navratil M; Đuranović V; Nogalo B; Švigir A; Dumbović Dubravčić I; Turkalj M
    Am J Case Rep; 2015 Sep; 16():631-6. PubMed ID: 26380989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ataxia-telangiectasia (A-T): An emerging dimension of premature ageing.
    Shiloh Y; Lederman HM
    Ageing Res Rev; 2017 Jan; 33():76-88. PubMed ID: 27181190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ataxia-telangiectasia: epidemiology, pathogenesis, clinical phenotype, diagnosis, prognosis and management.
    Amirifar P; Ranjouri MR; Lavin M; Abolhassani H; Yazdani R; Aghamohammadi A
    Expert Rev Clin Immunol; 2020 Sep; 16(9):859-871. PubMed ID: 32791865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.